Navigation Links
LIAI scientists make important finding on cytomegalovirus transmission

Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced ?and in some cases eliminated ?through the use of antibodies to enhance the disease-fighting power of the immune system. The research team’s findings, based on controlled laboratory studies of mice, may also have implications for other chronic virus infections, such as hepatitis and HIV, the virus that causes AIDS.

The team’s findings were published online this week in the Journal of Experimental Medicine in a paper entitled, "Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands." LIAI scientists Ian Humphreys, Ph.D., Carl Ware, Ph.D., and Michael Croft, Ph.D. led the study. CMV is a virus that affects the majority of the world’s population, but produces little or no symptoms in healthy individuals. However, it can cause multi-organ disease in newborns or persons who are immuno-compromised such as organ transplant recipients or AIDS patients.

Ware said, "The main importance of these experiments is identifying the critical molecular targets controlling virus persistence, and two ways in which we can modulate immunity in vivo with the desired result of blocking virus spread to uninfected individuals.

"The potential excitement in the findings is that we may be able to one day use this kind of treatment in humans to block or significantly reduce the spread of cytomegalovirus and other chronic virus infections." Ware noted that the salivary glands are a primary source of transmission for many viruses due to sneezing, coughing and kissing. Eliminating the virus at this critical juncture may significantly reduce CMV’s spread, he said.

In the study, Croft said the research team used an antibody to block the action of the IL-10 protein in the salivary glands of mice by inhibiting binding of IL-10 to its receptor. "IL-10 is a messenger molecule which suppresses
'"/>

Source:La Jolla Institute for Allergy and Immunology


Page: 1 2

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery

Post Your Comments:
(Date:11/8/2009)...WITH INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR...involving adults with intellectual disabilities fo...h knowledge after taking a semi-weekly class for f... accepted term for mental retardation, have slight...d preventable chronic diseases compared to the gen...
(Date:11/6/2009)...ell Center and the Chinese Academy of Sciences (CA...ng on Taste and Smell Research. Organized by Monel...be the first international meeting on taste and sm...xecutive Officer, American Association for the Adv...ence magazine, will open the meeting with a plenar...
(Date:11/4/2009)..., United States Using Less Water Today , The...5 years ago, despite a 30 percent population incre... to alternative cooling methods at power plants an...the latest USGS water use report, nearly half of a... thermoelectric power plants. Irrigation accounts ...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Film Event to Support United Cerebral Palsy 28UCP 29 of Central Arizona and the Phoenix Film Foundation 54975 1Film Event to Support United Cerebral Palsy 28UCP 29 of Central Arizona and the Phoenix Film Foundation 54975 2Reliability and benefit of diagnostic procedure for asthma in young children is unclear 54971 1Reliability and benefit of diagnostic procedure for asthma in young children is unclear 54971 2Reliability and benefit of diagnostic procedure for asthma in young children is unclear 54971 3Reliability and benefit of diagnostic procedure for asthma in young children is unclear 54971 4Night home hemodialysis shown to be as good as transplant in treating kidney failure 54967 1Night home hemodialysis shown to be as good as transplant in treating kidney failure 54967 2
...undamentally new "candidate," or potential, vaccin...that kills about 60,000 people annually, is report... Spread by the bite of infected female sand flies,...le annually, with the majority of cases occurring ...espite a major research thrust by the World Health...
...mists and engineers at the University of Toronto d... could help satisfy society,s never-ending hunger ...uld even lead to new methods for delivering medica...eriodic mesoporous organosilica (PMO), is a thin f... a metre across. The team created it by mixing an ...
...ed human bocavirus was found in nearly 5 percent o...very young children. Researchers from the Centers...indings today at the International Conference on E...a suggests that human bocavirus may be associated ... children," says Alicia Fry, one of the researcher...
Other Biology News:Potential vaccine developed for deadly leishmaniasis disease 2Potential vaccine developed for deadly leishmaniasis disease 3Bocavirus infection may be associated with pneumonia in Thailand, especially in children 2
(Date:11/6/2009)...v. 6 ,, 3Q09 Corpo...tenza(TM) E.U. Marketing Authorization to Astellas... commercial readiness activities Expanded managem...keting; and Director, Commercial Operations Appoi...Audit Committee chairman , Upcoming 2009 Mi...
(Date:11/6/2009)... 6 Intarcia Therapeutics, Inc. del...ROS® continuous delivery of exenatide) progra...h Annual Diabetes Technology Meeting in San Franci...bin/prnh/20050301/SFTU126LOGO ) ,, Continuous...owers Plasma Glucose, HbA1c and Reduces Weight in ...
(Date:11/5/2009)...v. 5 GenVec, Inc. (Nasda...or the third quarter ended September 30, 2009. Gen... share) for the three months ended September 30, 2...per share) in the comparable quarter of 2008. For ... net loss was $14.1 million ($0.15 per share), com...
(Date:11/5/2009)...Newswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulle...ncer, President and CEO of Imagenetix, will be pre...ICRO Conference on Thursday, December 3rd, at 10:3...About LD MICRO ,, LD MICRO is a by-invitation o...alued companies in the micro-cap space. Since 2002...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
..., , , , , , , RT-PCR ...es two PCR primers , that are specific for ..., allow differentiation between the amplifi...ct derived from contaminating genomic DNA. There a...ed primers (see figure below). , , , ,...
..., , , , , , , , ... cDNA produced. There , are three types o...on: , , Oligo(dT)1218, which binds...he 3, end of mammalian mRNA. This primer often pro... , Random hexanucleotides, which bind to ...
..., , , , , , , , ...tion, , , , , , , ,... Pack Size, , , ...ctions), , , , , , ... , Innovative , Tools for...
Other Biology Technology:
Direct ELISA Assay Diluent - EDTA from BioFX Laboratories, Inc.
UNICO Spectrophotometer from Femto Scientific
ZOOM® IEF Fractionator from Invitrogen
... Cloning Kits are designed to speed up the PCR clo...regardless of sequence or type of polymerase used,...g those that are difficult to clone by other PCR c... potentially detrimental proteins can be cloned an...
Biology Products: